Arriving in the arena of obesity therapy, retatrutide presents a different strategy. Beyond many existing medications, retatrutide operates as a dual agonist, concurrently targeting both GLP peptide-1 (GLP-1) and https://rafaelsszt478605.shotblogs.com/this-new-retatrutide-the-glp-gip-receptor-agonist-52636768